Ashish Manne

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Long Non Coding Rna

Metastatic Colorectal Cancer

Radiation Therapy

Top Venues

International journal of molecular sciences

Current oncology (Toronto, Ont.)

Journal of clinical medicine research

This page only lists publications with an associated author ORCID identifier.

Publications

Ashish Manne, Ashwini Kumar Esnakula, Ankur Sheel, Amir Sara, Upender Manne, Ravi Kumar Paluri, Kai He, Wancai Yang, Davendra Sohal, Anup Kasi, Anne M Noonan, Arjun Mittra, John Hays, Sameek Roychowdhury, Pannaga Malalur, Shafia Rahman, Ning Jin, Jordan M Cloyd, Susan Tsai, Aslam Ejaz, Kenneth Pitter, Eric D Miller, Kannan Thanikachalam, Mary Dillhoff, Lianbo Yu
Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and Outcomes. International journal of molecular sciences 25 (16) (2024)
Ashish Manne, Ashwini Kumar Esnakula, Ankur Sheel, Amir Sara, Upender Manne, Ravi Kumar Paluri, Kai He, Wancai Yang, Davendra Sohal, Anup Kasi, Anne M Noonan, Arjun Mittra, John Hays, Sameek Roychowdhury, Pannaga Malalur, Shafia Rahman, Ning Jin, Jordan M Cloyd, Susan Tsai, Aslam Ejaz, Kenneth Pitter, Eric D Miller, Kannan Thanikachalam, Mary Dillhoff, Lianbo Yu
Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and Outcomes. International journal of molecular sciences 25 (16) (2024)
Katherine K Benson, Ankur Sheel, Shafia Rahman, Ashwini Esnakula, Ashish Manne
Understanding the Clinical Significance of MUC5AC in Biliary Tract Cancers. Cancers 15 (2) (2023)
Samantha M Ruff, Ashish Manne, Jordan M Cloyd, Mary Dillhoff, Aslam Ejaz, Timothy M Pawlik
Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma. Current oncology (Toronto, Ont.) 30 (6) (2023)
Katherine K Benson, Ankur Sheel, Shafia Rahman, Ashwini Esnakula, Ashish Manne
Understanding the Clinical Significance of MUC5AC in Biliary Tract Cancers. Cancers 15 (2) (2023)
Samantha M Ruff, Ashish Manne, Jordan M Cloyd, Mary Dillhoff, Aslam Ejaz, Timothy M Pawlik
Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma. Current oncology (Toronto, Ont.) 30 (6) (2023)
Ashish Manne, Lianbo Yu, Phil A Hart, Allan Tsung, Ashwini Kumar Esnakula
Differential Expression and Diagnostic Value of MUC5AC Glycoforms in Pancreatic Ductal Adenocarcinoma. Cancers 15 (19) (2023)
Katherine K Benson, Ankur Sheel, Shafia Rahman, Ashwini Esnakula, Ashish Manne
Understanding the Clinical Significance of MUC5AC in Biliary Tract Cancers. Cancers 15 (2) (2023)
Sravan Jeepalyam, Ankur Sheel, Aslam Ejaz, Eric D Miller, Ashish Manne
Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time? International journal of molecular sciences 24 (18) (2023)
Benjin D Facer, Jordan M Cloyd, Ashish Manne, Kenneth L Pitter, Dayssy A Diaz, Jose G Bazan, Eric D Miller
Treatment Patterns and Outcomes for Patients with Ampullary Carcinoma Who Do Not Undergo Surgery. Cancers 15 (14) (2023)
Ashish Manne, Anup Kasi, Ashwini Kumar Esnakula, Ravi Kumar Paluri
Predictive Value of MUC5AC Signature in Pancreatic Ductal Adenocarcinoma: A Hypothesis Based on Preclinical Evidence. International journal of molecular sciences 24 (9) (2023)
Samantha M Ruff, Ashish Manne, Jordan M Cloyd, Mary Dillhoff, Aslam Ejaz, Timothy M Pawlik
Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma. Current oncology (Toronto, Ont.) 30 (6) (2023)
Samantha M Ruff, Ashish Manne, Jordan M Cloyd, Mary Dillhoff, Aslam Ejaz, Timothy M Pawlik
Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma. Current oncology (Toronto, Ont.) 30 (6) (2023)
Ashish Manne, Anup Kasi, Ashwini Kumar Esnakula, Ravi Kumar Paluri
Predictive Value of MUC5AC Signature in Pancreatic Ductal Adenocarcinoma: A Hypothesis Based on Preclinical Evidence. International journal of molecular sciences 24 (9) (2023)
Ankur Sheel, Sarah Addison, Surya Pratik Nuguru, Ashish Manne
Is Cell-Free DNA Testing in Pancreatic Ductal Adenocarcinoma Ready for Prime Time? Cancers 14 (14) (2022)
Edward Woods, Dat Le, Bharath Kumar Jakka, Ashish Manne
Changing Landscape of Systemic Therapy in Biliary Tract Cancer. Cancers 14 (9) (2022)
Joanna Jiang, Dayssy Alexandra Diaz, Surya Pratik Nuguru, Arjun Mittra, Ashish Manne
Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma. Cancers 15 (1) (2022)
Joanna Jiang, Dayssy Alexandra Diaz, Surya Pratik Nuguru, Arjun Mittra, Ashish Manne
Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma. Cancers 15 (1) (2022)
Joanna Jiang, Dayssy Alexandra Diaz, Surya Pratik Nuguru, Arjun Mittra, Ashish Manne
Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma. Cancers 15 (1) (2022)
Ashish Manne, Ashwini Esnakula, Laith Abushahin, Allan Tsung
Understanding the Clinical Impact of MUC5AC Expression on Pancreatic Ductal Adenocarcinoma. Cancers 13 (12) (2021)
Ashish Manne, Madhuri S Mulekar, Daisy E Escobar, Alhareth Alsayed, Gaurav Sharma, Pranitha Prodduturvar, Moh'd Khushman, John Harrison Howard, Robert Gilbert, Omar Alkharabsheh
Clinical and Hematological Predictors of High-Grade Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors. Journal of clinical medicine research 13 (5) (2021)